Income StatementBalance SheetCash FlowSegments
Elevance Health logo

Elevance Health Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Elevance Health holds $125.83B in total assets. Shareholders' equity is $43.9B against $32.2B in total debt. Cash and equivalents total $9.7B. The current ratio is 1.48 and debt-to-equity is 0.734. Based on the Q1 2026 filing.

Total Assets$125.83BTotal Stockholders Equity$43.9BLong Term Debt$30.8BCash And Equivalents$9.7BTotal Current Assets$67.0BTotal Current Liabilities$45.3B
Latest FilingQ1 2026
Report Date2026-04-22
Market Cap$84.2B
P/E Ratio16.06
ROE12.14%

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$8.9B$8.9B$8.9B$8.9B$8.9B$8.8B
Accumulated other comprehensive income (loss)-$1.1B-$911.0M-$760.0M-$543.0M-$451.0M-$741.0M
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0.0$0.0$0.0$0.0$0.0$0.0
Retained earnings$33.5B$34.5B$35.5B$35.6B$35.4B$35.8B
Total liabilities and stockholders' equity$116.9B$119.7B$121.9B$122.7B$121.5B$125.8B
Total stockholders' equity$41.3B$42.5B$43.7B$44.0B$43.9B$43.9B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cash and cash equivalents$8.3B$7.5B$8.6B$8.7B$9.5B$9.7B
Available For Sale Securities Debt Securities Current$25.2B$25.4B$25.3B$26.3B$25.9B$25.9B
Other current assets$4.7B$5.3B$5.4B$5.2B$5.3B$7.2B
Self-funded receivables, net$5.0B$5.2B$5.5B$5.1B$5.2B$5.1B
Premiums receivable$8.0B$10.4B$10.5B$9.5B$10.1B$11.5B
Short-term investments$25.2B$25.4B$25.3B$26.3B$25.9B$25.9B
Total current assets$58.9B$61.1B$63.3B$63.8B$63.0B$67.0B

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable and other current liabilities (Note 11)$6.9B$7.1B$7.3B$6.1B$7.3B$6.2B
Liability for Claims and Claims Adjustment Expense$15.7B$16.8B$17.2B$17.1B$17.1B$18.4B
Other accrued liabilities$10.0B$11.4B$12.3B$12.4B$10.3B$14.0B
Current portion of long-term debt$365.0M$250.0M$360.0M$180.0M$150.0M$724.0M
Reserve for Incurred But Not Reported (IBNR) Claims$4.2B$3.8B$3.5B$2.4B$3.6B$3.9B
Unearned premiums$1.5B$1.6B$1.6B$1.8B$1.5B$1.8B
Short-term borrowings$365.0M$250.0M$360.0M$180.0M$150.0M$724.0M
Total current liabilities$40.6B$42.7B$43.8B$40.9B$41.0B$45.3B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Goodwill$28.3B$28.4B$28.4B$28.5B$28.3B$28.3B
Equity securities$1.2B$715.0M$934.0M$1.2B$740.0M$1.5B
Long-term marketable securities$1.0B$1.1B$1.1B$1.1B$1.1B$1.1B
Other intangible assets—net$12.1B$11.9B$11.5B$11.3B$11.2B$11.1B
Other non-current assets$2.1B$2.4B$2.6B$2.8B$2.3B$2.6B
Strategic investments$9.7B$10.2B$10.5B$10.6B$10.8B$11.0B
Other Investments$9.7B$10.2B$10.5B$10.6B$10.8B$11.0B
Property and equipment, net$4.7B$4.6B$4.6B$4.7B$4.7B$4.7B
Software and Technology Licenses, Net$2.1B$2.4B$2.6B$2.8B$2.3B$2.6B
Total assets$116.9B$119.7B$121.9B$122.7B$121.5B$125.8B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Long-term debt$29.2B$28.1B$28.2B$31.2B$30.8B$30.8B
Other non-current liabilities$3.3B$4.0B$3.9B$4.1B$3.5B$3.9B
Total liabilities$75.5B$77.1B$78.1B$78.7B$77.5B$81.8B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Deferred income taxes$2.1B$2.1B$2.0B$2.3B$2.1B$1.8B
Noncontrolling interests in subsidiaries$111.0M$117.0M$129.0M$129.0M$144.0M$140.0M
Other receivables$6.0B$6.6B$7.2B$7.7B$6.3B$6.2B
Preferred Stock, Shares Authorized100M——100M100M100M
Preferred Stock, Shares Issued0——000
Preferred Stock, Shares Outstanding0——000